| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2017 | Crowley John F67 | Chairman &CEO | Sale+OE | 12,206 | $13.52 | $164,972.63 | -3.6% | |
| Dec 4, 2017 | Crowley John F67 | Chairman &CEO | Sale+OE | 47,213 | $13.61 | $642,734.18 | -12.6% | |
| Dec 1, 2017 | Barth Jay | Chief Medical Officer | Sale+OE | 5,000 | $13.59 | $67,937.00 | -7.2% | |
| Oct 18, 2017 | Crowley John F67 | Chairman &CEO | Sale+OE | 71,735 | $14.75 | $1,058,193.92 | -9.9% | |
| Oct 16, 2017 | Crowley John F67 | Chairman &CEO | Sale+OE | 449,295 | $14.33 | $6,436,917.90 | -31.3% | |
| Oct 12, 2017 | Baird William D III | Chief Financial Officer | Sale+OE | 40,000 | $14.25 | $570,132.00 | -29.6% | |
| Oct 12, 2017 | Barth Jay | Chief Medical Officer | Sale+OE | 5,000 | $14.25 | $71,268.00 | -7.2% | |
| Oct 12, 2017 | Do Hung | Chief Science Officer | Sale+OE | 50,194 | $14.25 | $715,359.87 | -9.6% | |
| Oct 12, 2017 | Quimi Daphne58 | SVP, Finance | Sale+OE | 7,000 | $14.25 | $99,739.50 | -11.3% | |
| Oct 12, 2017 | Raab Michael56 | Director | Sale+OE | 10,000 | $14.25 | $142,534.00 | -63.2% |